Jana Small Finance Bank Ltd
₹405.25
+27.80 (7.37%)
Fri, 06 Nov 2026, 10:04 pm
Jana Small Finance Bank News
Jana Small Finance Bank appoints Sneha Sharma as CS
Jana Small Finance Bank appoints Sneha Sharma as Company Secretary and Compliance Officer effective November 1, 2026. She brings a decade of governance experience.
23 Oct 2026
companies
Jana SFB Q2 Net Profit Jumps to ₹170 Crore
Jana Small Finance Bank reports Q2 net profit of ₹1.7 billion vs ₹750 million YoY. Revenue rises to ₹16 billion. GNPA improves to 2.34%, but NNPA widens to 1.17%.
23 Oct 2026
companies
Jana Small Finance Bank holds 20th AGM via VC
Jana Small Finance Bank conducted its 20th Annual General Meeting on September 29, 2026, via video conferencing. The meeting was chaired by Mrs. Chitra Talwar with 55 members present.
29 Sept 2026
companies
Jana Small Finance Bank appoints Rajeev K as Head of Internal Audit
Jana Small Finance Bank appoints Rajeev K as Head of Internal Audit effective September 28, 2026, succeeding Ramachandran who retires after seven years of service.
28 Sept 2026
companies
Jana SFB re-appoints K S Raman as ED
Jana Small Finance Bank re-appoints K S Raman as Executive Director for three years starting Jan 1, 2027, following RBI approval.
17 Sept 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo